Abbott.com via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Abbott.com' source. Thu, 09 Feb 2012 01:31:28 +0100 Abbott Creates New Similac SimplySmart™ Baby Bottle with Innovative Features http://www.medworm.com/index.php?rid=5669468&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2012-february08.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5669468 Wed, 08 Feb 2012 18:00:00 +0100 5669468 Abbott to Present at Leerink Swann 2012 Global Healthcare Conference http://www.medworm.com/index.php?rid=5651587&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2012-february01.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5651587 Wed, 01 Feb 2012 12:00:00 +0100 5651587 DNDi and Abbott Expand Partnership to Boost Innovation for Neglected Tropical Diseases http://www.medworm.com/index.php?rid=5651588&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2012-january30.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5651588 Mon, 30 Jan 2012 12:00:00 +0100 5651588 Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Fourth Quarter and Full-Year 2011 http://www.medworm.com/index.php?rid=5631223&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2012-january25.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5631223 Wed, 25 Jan 2012 12:00:00 +0100 5631223 Abbott’s STARLIMS LIMS Technology to be Installed in FDA Testing Laboratories http://www.medworm.com/index.php?rid=5612270&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2012-january18.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5612270 Wed, 18 Jan 2012 12:00:00 +0100 5612270 Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2011 Earnings http://www.medworm.com/index.php?rid=5562957&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2012-january4.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5562957 Wed, 04 Jan 2012 12:00:00 +0100 5562957 Abbott Initiates Clinical Trial to Study Drug Eluting Bioresorbable Therapy for Treatment of Peripheral Artery Disease http://www.medworm.com/index.php?rid=5527944&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-december22.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5527944 Thu, 22 Dec 2011 12:00:00 +0100 5527944 Abbott and University of Illinois Establish Center for Nutrition, Learning and Memory http://www.medworm.com/index.php?rid=5516895&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-december19.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5516895 Mon, 19 Dec 2011 12:00:00 +0100 5516895 Abbott to Present at J.P. Morgan Healthcare Conference http://www.medworm.com/index.php?rid=5507604&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-december15.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5507604 Thu, 15 Dec 2011 12:00:00 +0100 5507604 Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators http://www.medworm.com/index.php?rid=5497021&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-december12.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5497021 Mon, 12 Dec 2011 12:00:00 +0100 5497021 Abbott Declares 352nd Consecutive Quarterly Dividend http://www.medworm.com/index.php?rid=5489235&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-december09.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5489235 Fri, 09 Dec 2011 12:00:00 +0100 5489235 Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent http://www.medworm.com/index.php?rid=5489236&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-december08.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5489236 Thu, 08 Dec 2011 12:00:00 +0100 5489236 Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels http://www.medworm.com/index.php?rid=5460733&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-november30.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5460733 Wed, 30 Nov 2011 12:00:00 +0100 5460733 Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen http://www.medworm.com/index.php?rid=5451076&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov28.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5451076 Mon, 28 Nov 2011 12:00:00 +0100 5451076 Abbott Introduces the First FDA-Approved Supplemental Blood Test for Chagas Disease http://www.medworm.com/index.php?rid=5433708&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov21.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433708 Mon, 21 Nov 2011 12:00:00 +0100 5433708 Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011 http://www.medworm.com/index.php?rid=5433709&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov15.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433709 Tue, 15 Nov 2011 18:00:00 +0100 5433709 New Data Reinforce Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold http://www.medworm.com/index.php?rid=5433710&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov14.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433710 Mon, 14 Nov 2011 18:00:00 +0100 5433710 Abbott Receives CE Mark for New Hepatitis Test http://www.medworm.com/index.php?rid=5433711&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov9.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433711 Wed, 09 Nov 2011 18:00:00 +0100 5433711 Abbott Reports Five-Year Data for HUMIRA® (Adalimumab) in Ankylosing Spondylitis http://www.medworm.com/index.php?rid=5433712&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov8.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433712 Tue, 08 Nov 2011 18:00:00 +0100 5433712 Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis http://www.medworm.com/index.php?rid=5433713&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov7.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433713 Mon, 07 Nov 2011 18:00:00 +0100 5433713 Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA http://www.medworm.com/index.php?rid=5433714&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov6.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433714 Mon, 07 Nov 2011 00:00:00 +0100 5433714 Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis http://www.medworm.com/index.php?rid=5433716&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov4-2.htm Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433716 Fri, 04 Nov 2011 17:00:00 +0100 5433716 Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility http://www.medworm.com/index.php?rid=5433715&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov4.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433715 Fri, 04 Nov 2011 17:00:00 +0100 5433715 Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis http://www.medworm.com/index.php?rid=5391470&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-release%2F2011-nov4-2.htm Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5391470 Fri, 04 Nov 2011 11:00:00 +0100 5391470 Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility http://www.medworm.com/index.php?rid=5391469&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-nov4.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5391469 Fri, 04 Nov 2011 11:00:00 +0100 5391469 Abbott to Present New Data for Key Vascular Products at TCT 2011 http://www.medworm.com/index.php?rid=5433718&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433718 Thu, 03 Nov 2011 17:00:00 +0100 5433718 PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition http://www.medworm.com/index.php?rid=5433717&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov3-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433717 Thu, 03 Nov 2011 17:00:00 +0100 5433717 Abbott to Present New Data for Key Vascular Products at TCT 2011 http://www.medworm.com/index.php?rid=5367740&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-nov3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5367740 Thu, 03 Nov 2011 11:00:00 +0100 5367740 Abbott to Present at 2011 Credit Suisse Annual Health Care Conference http://www.medworm.com/index.php?rid=5433721&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov2-3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433721 Wed, 02 Nov 2011 17:00:00 +0100 5433721 Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting http://www.medworm.com/index.php?rid=5433720&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433720 Wed, 02 Nov 2011 17:00:00 +0100 5433720 Experts Report that Abbott’s New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense http://www.medworm.com/index.php?rid=5433719&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov2-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433719 Wed, 02 Nov 2011 17:00:00 +0100 5433719 Abbott to Present at 2011 Credit Suisse Annual Health Care Conference http://www.medworm.com/index.php?rid=5367744&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-nov2-3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5367744 Wed, 02 Nov 2011 11:00:00 +0100 5367744 Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting http://www.medworm.com/index.php?rid=5367743&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-nov2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5367743 Wed, 02 Nov 2011 11:00:00 +0100 5367743 Experts Report that Abbott’s New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense http://www.medworm.com/index.php?rid=5367742&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-nov2-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5367742 Wed, 02 Nov 2011 11:00:00 +0100 5367742 Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent http://www.medworm.com/index.php?rid=5433722&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-nov1.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433722 Tue, 01 Nov 2011 17:00:00 +0100 5433722 Abbott's Lupron Depot-PED (leuprolide acetate for depot suspension) 1-Month Formulation Now Includes 18-Year Long-Term Data in Label http://www.medworm.com/index.php?rid=5433723&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct27-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433723 Thu, 27 Oct 2011 17:00:00 +0100 5433723 Abbott Launches Glucerna® Hunger Smart™ Nutrition Products for People with Diabetes http://www.medworm.com/index.php?rid=5367746&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct27.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5367746 Thu, 27 Oct 2011 17:00:00 +0100 5367746 Abbott's Lupron Depot-PED (leuprolide acetate for depot suspension) 1-Month Formulation Now Includes 18-Year Long-Term Data in Label http://www.medworm.com/index.php?rid=5367747&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-oct27-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5367747 Thu, 27 Oct 2011 11:00:00 +0100 5367747 Abbott Awards CFCareForward Scholarships to Two Students Living with Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees http://www.medworm.com/index.php?rid=5350692&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct25.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5350692 Tue, 25 Oct 2011 11:00:00 +0100 5350692 Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA http://www.medworm.com/index.php?rid=5350694&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct24-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5350694 Mon, 24 Oct 2011 11:00:00 +0100 5350694 Abbott Honored With Asian CSR Award for Leadership in Science Education http://www.medworm.com/index.php?rid=5350693&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct24.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5350693 Mon, 24 Oct 2011 11:00:00 +0100 5350693 Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select Phase 2b Trial at ECTRIMS/ACTRIMS http://www.medworm.com/index.php?rid=5339162&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct22.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5339162 Sat, 22 Oct 2011 17:00:00 +0100 5339162 Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals http://www.medworm.com/index.php?rid=5433724&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct19-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433724 Wed, 19 Oct 2011 17:00:00 +0100 5433724 Abbott Reports Strong Ongoing Third Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2011 http://www.medworm.com/index.php?rid=5339163&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct19.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5339163 Wed, 19 Oct 2011 11:00:00 +0100 5339163 Abbott's ABSORB™ Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award http://www.medworm.com/index.php?rid=5326194&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct17.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5326194 Mon, 17 Oct 2011 11:00:00 +0100 5326194 Abbott Hosts Conference Call for Third-Quarter Earnings http://www.medworm.com/index.php?rid=5288420&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct5.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5288420 Wed, 05 Oct 2011 11:00:00 +0100 5288420 Abbott Enrolls First U.S. Patient in Global EXCEL Trial Comparing XIENCE to Coronary Artery Bypass Surgery http://www.medworm.com/index.php?rid=5288421&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-oct4.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5288421 Tue, 04 Oct 2011 17:00:00 +0100 5288421 Abbott Announces Availability of Two New CE-Marked Molecular Assays for its m2000 System to Detect Infections Spread in Healthcare Settings http://www.medworm.com/index.php?rid=5263794&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept29.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5263794 Thu, 29 Sep 2011 11:00:00 +0100 5263794 Abbott Earns 100 Percent Banned Substance Free Certification for all of its EAS® Sports Nutrition Products http://www.medworm.com/index.php?rid=5433726&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept20_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433726 Tue, 20 Sep 2011 17:00:00 +0100 5433726 Abbott Named Top Dealmaker for Fourth Consecutive Year by The Deal http://www.medworm.com/index.php?rid=5433725&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept20.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5433725 Tue, 20 Sep 2011 11:00:00 +0100 5433725 Abbott Earns 100 Percent Banned Substance Free Certification for all of its EAS® Sports Nutrition Products http://www.medworm.com/index.php?rid=5241315&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-mediaa%2Fpress-releases%2F2011-sept20_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5241315 Tue, 20 Sep 2011 11:00:00 +0100 5241315 Abbott Again Recognized as One of the "Top Employers" in the Biotech and Pharmaceutical Industry by Science Magazine http://www.medworm.com/index.php?rid=5229058&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept15_2.htm Abbott Again Recognized as One of the "Top Employers" in the Biotech and Pharmaceutical Industry by Science Magazine (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5229058 Thu, 15 Sep 2011 11:00:00 +0100 5229058 Abbott Declares 351st Consecutive Quarterly Dividend http://www.medworm.com/index.php?rid=5229057&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept15_3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5229057 Thu, 15 Sep 2011 11:00:00 +0100 5229057 Abbott Named to Working Mother Magazine’s ‘Best Companies’ List for the Eleventh Consecutive Year http://www.medworm.com/index.php?rid=5229056&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept15.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5229056 Thu, 15 Sep 2011 11:00:00 +0100 5229056 Abbott Named to the Dow Jones Sustainability Indexes for Seventh Consecutive Year in Recognition of Leading Corporate Citizenship Performance http://www.medworm.com/index.php?rid=5212903&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept8_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5212903 Thu, 08 Sep 2011 11:00:00 +0100 5212903 Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia http://www.medworm.com/index.php?rid=5212902&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-sept8.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5212902 Thu, 08 Sep 2011 11:00:00 +0100 5212902 Abbott to Present at Morgan Stanley Global Healthcare Conference http://www.medworm.com/index.php?rid=5186710&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-aug31.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5186710 Wed, 31 Aug 2011 11:00:00 +0100 5186710 Abbott Awards CFCareForward Scholarships to 40 Exceptional Graduate and Undergraduate Students Living with Cystic Fibrosis http://www.medworm.com/index.php?rid=5176927&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-aug30_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5176927 Tue, 30 Aug 2011 11:00:00 +0100 5176927 Abbott Introduces New ALK Genetic Test for Specific Form of Non-Small-Cell Lung Cancer http://www.medworm.com/index.php?rid=5176926&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-aug30.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5176926 Tue, 30 Aug 2011 11:00:00 +0100 5176926 Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection http://www.medworm.com/index.php?rid=5165231&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-aug26.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5165231 Fri, 26 Aug 2011 11:00:00 +0100 5165231 Abbott Receives CE Mark for Healon EndoCoat Protective Gel for Cataract Surgery http://www.medworm.com/index.php?rid=5149532&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-aug22.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5149532 Mon, 22 Aug 2011 11:00:00 +0100 5149532 FDA Clears Abbott’s Genetic FISH Panel for Leukemia Patient Prognosis http://www.medworm.com/index.php?rid=5149531&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fnews-media%2Fpress-releases%2F2011-aug22-2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5149531 Mon, 22 Aug 2011 11:00:00 +0100 5149531 Abbott Receives FDA Approval for Two Three-Month Strengths of Lupron Depot-PED® (leuprolide acetate for depot suspension) for the Treatment of Central Precocious Puberty (CPP) http://www.medworm.com/index.php?rid=5134405&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-august16_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5134405 Tue, 16 Aug 2011 11:00:00 +0100 5134405 Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market http://www.medworm.com/index.php?rid=5134404&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-august17.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5134404 Tue, 16 Aug 2011 11:00:00 +0100 5134404 First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial http://www.medworm.com/index.php?rid=5134403&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-august16.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5134403 Tue, 16 Aug 2011 11:00:00 +0100 5134403 Abbott’s PediaSure® Brand Aims to Help Moms With Picky Eaters "Take Back the Table" By Building Lifelong Healthy Eating Habits http://www.medworm.com/index.php?rid=5121678&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-august11.htm Abbott’s PediaSure® Brand Aims to Help Moms With Picky Eaters "Take Back the Table" By Building Lifelong Healthy Eating Habits (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5121678 Thu, 11 Aug 2011 11:00:00 +0100 5121678 Abbott Introduces Vector-borne Pathogen Test to Detect Microorganisms Carried by Ticks and Other Insects http://www.medworm.com/index.php?rid=5112564&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-august10_1.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5112564 Wed, 10 Aug 2011 11:00:00 +0100 5112564 Abbott Receives U.S. FDA Approval for RX Herculink Elite® Renal Stent System for Treatment of Renal Artery Disease http://www.medworm.com/index.php?rid=5112563&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-august10.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5112563 Wed, 10 Aug 2011 11:00:00 +0100 5112563 Biogen Idec And Abbott Announce Positive Top-Line Results From The First Registrational Trial For Daclizumab HYP In Relapsing-Remitting Multiple Sclerosis http://www.medworm.com/index.php?rid=5112565&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-august9.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5112565 Tue, 09 Aug 2011 17:00:00 +0100 5112565 Data Presented at American Association for Clinical Chemistry Meeting Show Many Americans May Have Low Vitamin D Levels http://www.medworm.com/index.php?rid=5072717&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-july28.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5072717 Thu, 28 Jul 2011 11:00:00 +0100 5072717 Abbott’s HIV Combo Test Detects Infections Earlier, Provides Valuable Information to Help Prevent Further HIV Transmission and May Save Treatment Costs http://www.medworm.com/index.php?rid=5072718&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-july27.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5072718 Wed, 27 Jul 2011 11:00:00 +0100 5072718 Abbott to Feature Acute HIV Diagnostic, Metabolic Function Tests and Lab Informatics at American Association for Clinical Chemistry Annual Meeting http://www.medworm.com/index.php?rid=5043465&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-july21.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5043465 Thu, 21 Jul 2011 11:00:00 +0100 5043465 Abbott Reports 11 Percent Ongoing Earnings-Per-Share Growth in Second Quarter; Raises 2011 EPS Guidance Range http://www.medworm.com/index.php?rid=5043466&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-july20.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5043466 Wed, 20 Jul 2011 11:00:00 +0100 5043466 Abbott Confirms Long-Term Commitment to HIV Care with the Planned Development of New Formulations http://www.medworm.com/index.php?rid=5032429&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-july15.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=5032429 Fri, 15 Jul 2011 11:00:00 +0100 5032429 Abbott Hosts Conference Call for Second-Quarter Earnings http://www.medworm.com/index.php?rid=4979221&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fpress-release%2F2011-June29.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4979221 Wed, 29 Jun 2011 11:00:00 +0100 4979221 New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients with Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes http://www.medworm.com/index.php?rid=4963709&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June24.htm New Phase 2 Data Published in New England Journal of Medicine Show Bardoxolone Methyl Sustained Improvement in Measure of Kidney Function (eGFR) Over 52 Weeks in Patients with Moderate to Severe Chronic Kidney Disease and Type 2 Diabetes (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4963709 Fri, 24 Jun 2011 11:00:00 +0100 4963709 Abbott and Biotest Announce Global Agreement to Develop and Commercialize Novel Antibody for Autoimmune Diseases http://www.medworm.com/index.php?rid=4956417&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June21.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4956417 Tue, 21 Jun 2011 17:00:00 +0100 4956417 Abbott Receives FDA Approval for a New Six-Month Formulation of Lupron Depot® (leuprolide acetate for depot suspension) for the Palliative Treatment of Advanced Prostate Cancer http://www.medworm.com/index.php?rid=4948110&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June20.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4948110 Mon, 20 Jun 2011 11:00:00 +0100 4948110 Reata and Abbott Initiate Global Phase 3 Study of Bardoxolone Methyl in Patients with Chronic Kidney Disease and Type 2 Diabetes http://www.medworm.com/index.php?rid=4940805&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June16.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4940805 Thu, 16 Jun 2011 11:00:00 +0100 4940805 Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis http://www.medworm.com/index.php?rid=4979222&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June14.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4979222 Tue, 14 Jun 2011 11:00:00 +0100 4979222 Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis http://www.medworm.com/index.php?rid=4925831&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June14.htm Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4925831 Tue, 14 Jun 2011 11:00:00 +0100 4925831 New National Survey Results Reveal Majority of Men Find it Easier to Care for Their Car Than for Their Personal Health http://www.medworm.com/index.php?rid=4925832&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June13.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4925832 Mon, 13 Jun 2011 17:00:00 +0100 4925832 Abbott Declares 350th Consecutive Quarterly Dividend http://www.medworm.com/index.php?rid=4916325&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June10.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4916325 Fri, 10 Jun 2011 11:00:00 +0100 4916325 Abbott Reports Interim Results from Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease http://www.medworm.com/index.php?rid=4916326&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011June09.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4916326 Thu, 09 Jun 2011 11:00:00 +0100 4916326 Abbott Statement on Interim Study Results of AIM-HIGH http://www.medworm.com/index.php?rid=4867180&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May26.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4867180 Thu, 26 May 2011 11:00:00 +0100 4867180 Abbott Receives CE Mark for its RealTime Molecular Test for Cytomegalovirus http://www.medworm.com/index.php?rid=4857186&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May25.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4857186 Wed, 25 May 2011 11:00:00 +0100 4857186 Abbott to Present at Goldman Sachs 32nd Annual Global Healthcare Conference http://www.medworm.com/index.php?rid=4857185&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May25_1.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4857185 Wed, 25 May 2011 11:00:00 +0100 4857185 Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels http://www.medworm.com/index.php?rid=4857187&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May24.htm Abbott Receives U.S. FDA Approval for XIENCE nano™ to Treat Coronary Artery Disease in Small Vessels (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4857187 Tue, 24 May 2011 11:00:00 +0100 4857187 Abbott Completes Submission of New Molecular Test Intended for Non-small-cell Lung Cancer Therapy Selection http://www.medworm.com/index.php?rid=4857188&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May23.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4857188 Mon, 23 May 2011 11:00:00 +0100 4857188 Abbott Introduces New ZonePerfect® Sweet & Salty Nutrition Bars http://www.medworm.com/index.php?rid=4979223&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May20.htm Abbott Introduces New ZonePerfect® Sweet & Salty Nutrition Bars (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4979223 Fri, 20 May 2011 11:00:00 +0100 4979223 Abbott Introduces New ZonePerfect® Sweet & Salty Nutrition Bars http://www.medworm.com/index.php?rid=4844556&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May20.htm Abbott Introduces New ZonePerfect® Sweet & Salty Nutrition Bars (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4844556 Fri, 20 May 2011 11:00:00 +0100 4844556 Abbott Statement on the FDA Advisory Committee Recommendations on Fenofibric Acid http://www.medworm.com/index.php?rid=4844557&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May19.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4844557 Thu, 19 May 2011 11:00:00 +0100 4844557 Study Shows Improved Patient Management and Outcome using Abbott’s Sensitive Troponin Assay http://www.medworm.com/index.php?rid=4835277&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May18_2.htm Study Shows Improved Patient Management and Outcome using Abbott’s Sensitive Troponin Assay (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4835277 Wed, 18 May 2011 11:00:00 +0100 4835277 Abbott Receives FDA Approval for Molecular Test for Hepatitis C http://www.medworm.com/index.php?rid=4835276&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May18.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4835276 Wed, 18 May 2011 11:00:00 +0100 4835276 Abbott's Labs Are Vital™ Honors University of Sheffield Team for Outstanding Research http://www.medworm.com/index.php?rid=4979224&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May16.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4979224 Mon, 16 May 2011 11:00:00 +0100 4979224 Abbott's Labs Are Vital™ Honors University of Sheffield Team for Outstanding Research http://www.medworm.com/index.php?rid=4835278&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May16.htm Abbott's Labs Are Vital™ Honors University of Sheffield Team for Outstanding Research (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4835278 Mon, 16 May 2011 11:00:00 +0100 4835278 Abbott Features Novel Biomarkers and Laboratory Automation at International Federation of Clinical Chemistry Congress http://www.medworm.com/index.php?rid=4823897&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May14.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4823897 Sat, 14 May 2011 11:00:00 +0100 4823897 Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study http://www.medworm.com/index.php?rid=4979225&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May10_3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4979225 Tue, 10 May 2011 11:00:00 +0100 4979225 Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study http://www.medworm.com/index.php?rid=4808329&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May10_3.htm Abbott's HUMIRA® (Adalimumab) Meets Primary Endpoints in Phase III Ulcerative Colitis Study (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4808329 Tue, 10 May 2011 11:00:00 +0100 4808329 Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Receives CE Mark http://www.medworm.com/index.php?rid=4808328&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May10.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4808328 Tue, 10 May 2011 11:00:00 +0100 4808328 Abbott Receives FDA Approval to Expand Use of the RX ACCULINK® Carotid Stent System to Patients at Standard Surgical Risk http://www.medworm.com/index.php?rid=4791778&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011May6.htm Abbott Receives FDA Approval to Expand Use of the RX ACCULINK® Carotid Stent System to Patients at Standard Surgical Risk (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4791778 Fri, 06 May 2011 11:00:00 +0100 4791778 Abbott to Present at Bank of America Merrill Lynch 2011 Health Care Conference http://www.medworm.com/index.php?rid=4777204&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011%2FMay3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4777204 Tue, 03 May 2011 11:00:00 +0100 4777204 Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone http://www.medworm.com/index.php?rid=4765236&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr29_2.htm Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low Testosterone (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4765236 Fri, 29 Apr 2011 11:00:00 +0100 4765236 Abbott Highlights Top-Tier Financial Performance, Strong Growth in Emerging Markets at Annual Meeting http://www.medworm.com/index.php?rid=4765235&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr29.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4765235 Fri, 29 Apr 2011 11:00:00 +0100 4765235 Abbott Reports 17.4 Percent Sales Growth and 12.3 Percent Ongoing Earnings-Per-Share Growth in First Quarter http://www.medworm.com/index.php?rid=4738093&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr20.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4738093 Wed, 20 Apr 2011 11:00:00 +0100 4738093 Abbott Chairman and CEO Miles D. White Elected to the American Academy of Arts & Sciences http://www.medworm.com/index.php?rid=4728292&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr19.htm Abbott Chairman and CEO Miles D. White Elected to the American Academy of Arts & Sciences (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4728292 Tue, 19 Apr 2011 11:00:00 +0100 4728292 New Fully Automated Vitamin D Assay Submitted for FDA Clearance http://www.medworm.com/index.php?rid=4716734&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr15.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4716734 Fri, 15 Apr 2011 11:00:00 +0100 4716734 Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment http://www.medworm.com/index.php?rid=4979226&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr04.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4979226 Mon, 04 Apr 2011 11:00:00 +0100 4979226 Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C http://www.medworm.com/index.php?rid=4673036&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr04_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4673036 Mon, 04 Apr 2011 11:00:00 +0100 4673036 Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment http://www.medworm.com/index.php?rid=4673035&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr04.htm Data from Landmark Clinical Trial of Abbott's MitraClip® System Demonstrate Durable Clinical Benefits for Patients with Mitral Regurgitation Two Years After Treatment (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4673035 Mon, 04 Apr 2011 11:00:00 +0100 4673035 Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results http://www.medworm.com/index.php?rid=4673038&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr03.htm Abbott's ABSORB Bioresorbable Vascular Scaffold Demonstrates Positive One-Year Safety and Efficacy Results (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4673038 Sun, 03 Apr 2011 11:00:00 +0100 4673038 Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V® http://www.medworm.com/index.php?rid=4673037&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Apr03_2.htm Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V® (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4673037 Sun, 03 Apr 2011 11:00:00 +0100 4673037 Abbott Introduces Hepatitis B Sequencing Test in Europe http://www.medworm.com/index.php?rid=4660678&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar31_1.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4660678 Thu, 31 Mar 2011 11:00:00 +0100 4660678 Abbott Hosts Conference Call for First-Quarter Earnings http://www.medworm.com/index.php?rid=4660677&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar31.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4660677 Thu, 31 Mar 2011 11:00:00 +0100 4660677 Abbott Announces Launch of Catheter-Based MitraClip® System in Australia for Mitral Regurgitation, the Most Common Heart Valve Condition http://www.medworm.com/index.php?rid=4655404&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar30.htm Abbott Announces Launch of Catheter-Based MitraClip® System in Australia for Mitral Regurgitation, the Most Common Heart Valve Condition (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4655404 Wed, 30 Mar 2011 11:00:00 +0100 4655404 FDA Clears Abbott’s i-STAT® 1 Wireless Point of Care Testing System http://www.medworm.com/index.php?rid=4647512&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar29.htm FDA Clears Abbott’s i-STAT® 1 Wireless Point of Care Testing System (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4647512 Tue, 29 Mar 2011 11:00:00 +0100 4647512 Abbott Introduces Micro-Implantation Cataract Suite http://www.medworm.com/index.php?rid=4647514&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar28_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4647514 Mon, 28 Mar 2011 11:00:00 +0100 4647514 Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011 http://www.medworm.com/index.php?rid=4647513&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar28.htm Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011 (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4647513 Mon, 28 Mar 2011 11:00:00 +0100 4647513 Abbott Recognizes Winners of Supplier Excellence Award http://www.medworm.com/index.php?rid=4628668&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar24.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4628668 Thu, 24 Mar 2011 11:00:00 +0100 4628668 Abbott's New HIV-1 Qualitative Assay Improves Testing Access in Remote Areas for Children and Adults http://www.medworm.com/index.php?rid=4618485&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar21.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4618485 Mon, 21 Mar 2011 11:00:00 +0100 4618485 Abbott Supports Relief Efforts in Japan http://www.medworm.com/index.php?rid=4585420&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar14.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4585420 Mon, 14 Mar 2011 11:00:00 +0100 4585420 Positive Results from Phase 2 Study of Atrasentan for Treatment of Diabetic Kidney Disease Published in the Journal of the American Society of Nephrology http://www.medworm.com/index.php?rid=4546647&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar04.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4546647 Fri, 04 Mar 2011 06:00:00 +0100 4546647 Abbott to Present at Barclays Capital 2011 Global Healthcare Conference http://www.medworm.com/index.php?rid=4534175&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Mar01.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4534175 Tue, 01 Mar 2011 06:00:00 +0100 4534175 Abbott Launches a CE Marked KIF6 Test in Europe http://www.medworm.com/index.php?rid=4504093&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Feb22_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4504093 Tue, 22 Feb 2011 06:00:00 +0100 4504093 Abbott to Present at Cowen and Company 31st Annual Health Care Conference http://www.medworm.com/index.php?rid=4504092&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Feb22.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4504092 Tue, 22 Feb 2011 06:00:00 +0100 4504092 Abbott Announces Increase in Quarterly Dividend http://www.medworm.com/index.php?rid=4491817&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Feb18.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4491817 Fri, 18 Feb 2011 06:00:00 +0100 4491817 Abbott to Present at RBC Capital Markets' Healthcare Conference http://www.medworm.com/index.php?rid=4479594&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Feb15.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4479594 Tue, 15 Feb 2011 06:00:00 +0100 4479594 Abbott’s Ibis Technology Identified Fatal Disease Organism in Afghanistan http://www.medworm.com/index.php?rid=4443381&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Feb07_2.htm Abbott’s Ibis Technology Identified Fatal Disease Organism in Afghanistan (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4443381 Mon, 07 Feb 2011 06:00:00 +0100 4443381 Abbott Introduces Biothreat Assay for PLEX-ID™ System http://www.medworm.com/index.php?rid=4443380&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Feb07.htm Abbott Introduces Biothreat Assay for PLEX-ID™ System (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4443380 Mon, 07 Feb 2011 06:00:00 +0100 4443380 Chicagoland Media Advisory:Abbott's Chicagoland Operations Close Today due to Weather Conditions http://www.medworm.com/index.php?rid=4426202&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Feb02.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4426202 Wed, 02 Feb 2011 06:00:00 +0100 4426202 Abbott's TREK® Coronary Balloon System Now Available in the United States and Japan http://www.medworm.com/index.php?rid=4416256&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Jan31.htm Abbott's TREK® Coronary Balloon System Now Available in the United States and Japan (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4416256 Mon, 31 Jan 2011 06:00:00 +0100 4416256 FDA Advisory Committee Votes Favorably on Expanding the Indication for Abbott's Carotid Stent System to Include Patients at Standard Surgical Risk http://www.medworm.com/index.php?rid=4402354&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Jan26_2.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4402354 Wed, 26 Jan 2011 06:00:00 +0100 4402354 Abbott Reports Double-Digit Sales and Ongoing Earnings Growth in Fourth Quarter; Issues Ongoing Earnings Outlook for 2011 http://www.medworm.com/index.php?rid=4402353&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Jan26.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4402353 Wed, 26 Jan 2011 06:00:00 +0100 4402353 New Abbott Vitamin D Test Available for Use in the European Union http://www.medworm.com/index.php?rid=4396173&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Jan25.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4396173 Tue, 25 Jan 2011 06:00:00 +0100 4396173 Abbott Receives CE Mark Approval for World's First  Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease http://www.medworm.com/index.php?rid=4328257&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Jan10.htm Abbott Receives CE Mark Approval for World's First  Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4328257 Mon, 10 Jan 2011 06:00:00 +0100 4328257 Partners In Health, Abbott and the Abbott Fund Unite to Combat Severe Childhood Malnutrition in Haiti http://www.medworm.com/index.php?rid=4320050&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Jan7.htm Partners In Health, Abbott and the Abbott Fund Unite to Combat Severe Childhood Malnutrition in Haiti (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4320050 Fri, 07 Jan 2011 06:00:00 +0100 4320050 Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2010 Earnings http://www.medworm.com/index.php?rid=4306839&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2011Jan3.htm (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4306839 Mon, 03 Jan 2011 06:00:00 +0100 4306839 Update: Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico http://www.medworm.com/index.php?rid=4290871&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2010Dec23.htm Update: Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4290871 Thu, 23 Dec 2010 06:00:00 +0100 4290871 Update: Abbott Diabetes Care Announces Recall of Certain Lots of Precision Xtra®, Precision Xceed Pro®, MediSense® Optium™, Optium™, OptiumEZ and ReliOn® Ultima Blood Glucose Test Strips in the United States and Puerto Rico http://www.medworm.com/index.php?rid=4286519&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2Fglobal%2Furl%2FpressRelease%2Fen_US%2F60.5%3A5%2FPress_Release_0934.htm%3Freferrer%3DRSS (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4286519 Thu, 23 Dec 2010 06:00:00 +0100 4286519 Abbott and AstraZeneca End License Agreement for the Development of CERTRIAD™ http://www.medworm.com/index.php?rid=4290873&cid=s_37972_34_f&fid=37972&url=http%3A%2F%2Fwww.abbott.com%2FPressRelease%2F2010Dec22-3.htm Abbott and AstraZeneca End License Agreement for the Development of CERTRIAD™ (Source: Abbott.com) Abbott.com news http://www.medworm.com/rss/comments.php?id=4290873 Wed, 22 Dec 2010 06:00:00 +0100 4290873